A closely-watched Gilead Sciences Inc experimental antiviral drug failed to help patients with severe COVID-19 in a clinical trial conducted in China, but the drugmaker said the findings were inconclusive because the study was terminated early.
UK: Gilead disputes report that its drug flopped in leaked coronavirus trial
![UK: Gilead disputes report that its drug flopped in leaked coronavirus trial]()
Reviewed by Shahid Karimi
on
April 23, 2020
Rating:
No comments: